Form 4 for AMPH Amphastar Pharmaceuticals, Inc.
Accepted 2022-03-17 00:00:00 ET · period of report 2022-03-15 · accession 0001104659-22-035104 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-17 | 2022-03-15 | AMPH | Liawatidewi Yakob | EVP Corp Admin Center | A - Grant | $0.00 | +11.5K | 65.6K | +21% | $0 |
| D | 2022-03-17 | 2022-03-15 | AMPH | Liawatidewi Yakob | EVP Corp Admin Center | F - Tax | $34.74 | -1,559 | 64.0K | -2% | -$54.2K |
| D | 2022-03-17 | 2022-03-15 | AMPH | Liawatidewi Yakob | EVP Corp Admin Center | A - Grant | $0.00 | +26.6K | 26.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-15 | A | A | 11,514 | $0.00 | 65,591 | D | — | — | (F1) The reported shares are represented by restricted stock units, or RSUs, which vest in four equal annual installments beginning on March 15, 2023. |
| 2 | Common | Common Stock | 2022-03-15 | F | D | 1,559 | $34.74 | 64,032 | D | — | — | (F2) The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of RSUs. |
| 3 | Derivative | Employee Stock Option (right to buy) | 2022-03-15 | A | A | 26,567 | $0.00 | 26,567 | D | $34.74 · — to 2032-03-15 | 26,567 Common Stock | (F4) The shares subject to the option vest in four equal annual installments beginning on March 15, 2023. |